Literature DB >> 18474653

Macrophage migration inhibitory factor and interleukin-8 produced by gastric epithelial cells during Helicobacter pylori exposure induce expression and activation of the epidermal growth factor receptor.

Ellen J Beswick1, Victor E Reyes.   

Abstract

While a link between Helicobacter pylori exposure and gastric cancer has been established, the underlying mechanisms remain unclear. H. pylori induces a chronic inflammatory response in infected individuals. A link between chronic inflammation and carcinogenesis has long been suggested but never elucidated. Epidermal growth factor receptor (EGFR) signaling plays an important role in both proinflammatory and procarcinogenic mechanisms and is upregulated on gastric epithelial cells (GECs) during H. pylori exposure. The aim of this study was to examine the effects of two important proinflammatory cytokines released during H. pylori infection, macrophage migration inhibitory factor (MIF) and interleukin-8 (IL-8), on the expression and transactivation of EGFR and on the proliferation of GECs during H. pylori exposure. The expression of EGFR by GECs was increased by exposure to either H. pylori, recombinant MIF, or recombinant IL-8. However, cag pathogenicity island knockout strains of H. pylori had very little effect on expression. MIF and IL-8 also induced phosphorylation of EGFR, signaling events, and proliferation during H. pylori exposure, all of which were decreased when they were neutralized by these cytokines or were blocked from their receptors. The overall role of EGFR in these responses to H. pylori exposure was assessed by knocking down EGFR expression by small interfering RNA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474653      PMCID: PMC2446686          DOI: 10.1128/IAI.01534-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Helicobacter pylori CagA transfection of gastric epithelial cells induces interleukin-8.

Authors:  Seok-Yong Kim; Yong-Chan Lee; Hyong Kyu Kim; Martin J Blaser
Journal:  Cell Microbiol       Date:  2006-01       Impact factor: 3.715

2.  Macrophage migration inhibitory factor has a proinflammatory activity via the p38 pathway in glucocorticoid-resistant ulcerative colitis.

Authors:  Yoh Ishiguro; Tatsuya Ohkawara; Hirotake Sakuraba; Kazufumi Yamagata; Hiroto Hiraga; Satoko Yamaguchi; Shinsaku Fukuda; Akihiro Munakata; Akio Nakane; Jun Nishihira
Journal:  Clin Immunol       Date:  2006-06-27       Impact factor: 3.969

3.  Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis.

Authors:  S Onodera; K Kaneda; Y Mizue; Y Koyama; M Fujinaga; J Nishihira
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

Review 4.  ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors.

Authors:  Haruhiko Ohtsu; Peter J Dempsey; Satoru Eguchi
Journal:  Am J Physiol Cell Physiol       Date:  2006-07       Impact factor: 4.249

5.  The Helicobacter pylori urease B subunit binds to CD74 on gastric epithelial cells and induces NF-kappaB activation and interleukin-8 production.

Authors:  Ellen J Beswick; Irina V Pinchuk; Kyle Minch; Giovanni Suarez; Johanna C Sierra; Yoshio Yamaoka; Victor E Reyes
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

6.  MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.

Authors:  Jürgen Bernhagen; Regina Krohn; Hongqi Lue; Julia L Gregory; Alma Zernecke; Rory R Koenen; Manfred Dewor; Ivan Georgiev; Andreas Schober; Lin Leng; Teake Kooistra; Günter Fingerle-Rowson; Pietro Ghezzi; Robert Kleemann; Shaun R McColl; Richard Bucala; Michael J Hickey; Christian Weber
Journal:  Nat Med       Date:  2007-04-15       Impact factor: 53.440

7.  Helicobacter pylori CagA-dependent macrophage migration inhibitory factor produced by gastric epithelial cells binds to CD74 and stimulates procarcinogenic events.

Authors:  Ellen J Beswick; Irina V Pinchuk; Giovanni Suarez; Johanna C Sierra; Victor E Reyes
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

Review 8.  H pylori and host interactions that influence pathogenesis.

Authors:  Ellen J Beswick; Giovanni Suarez; Victor E Reyes
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

9.  Expression of epidermal growth factor receptor (EGFR) is frequent in inflammatory bowel disease (IBD)-associated intestinal cancer.

Authors:  Magali Svrcek; Jacques Cosnes; Emmanuel Tiret; Malika Bennis; Yann Parc; Jean-François Fléjou
Journal:  Virchows Arch       Date:  2007-02       Impact factor: 4.064

10.  Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.

Authors:  H Lue; M Thiele; J Franz; E Dahl; S Speckgens; L Leng; G Fingerle-Rowson; R Bucala; B Lüscher; J Bernhagen
Journal:  Oncogene       Date:  2007-02-19       Impact factor: 9.867

View more
  15 in total

1.  Trichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responses.

Authors:  Olivia Twu; Daniele Dessí; Anh Vu; Frances Mercer; Grant C Stevens; Natalia de Miguel; Paola Rappelli; Anna Rita Cocco; Robert T Clubb; Pier Luigi Fiori; Patricia J Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

2.  CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.

Authors:  Ying-Xia Zheng; Ming Yang; Ting-Ting Rong; Xiang-Liang Yuan; Yan-Hui Ma; Zhi-Hao Wang; Li-Song Shen; Long Cui
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

3.  Association of LEC and tnpA Helicobacter pylori genes with gastric cancer in a Brazilian population.

Authors:  Rejane Mattar; Maria S Monteiro; Sergio B Marques; Bruno Zilberstein; Cláudio L Hashimoto; Flair J Carrilho
Journal:  Infect Agent Cancer       Date:  2010-01-11       Impact factor: 2.965

4.  Enhanced expression of CD74 in gastrointestinal cancers and benign tissues.

Authors:  David V Gold; Rhona Stein; Jack Burton; David M Goldenberg
Journal:  Int J Clin Exp Pathol       Date:  2010-11-23

Review 5.  CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract.

Authors:  Ellen J Beswick; Victor E Reyes
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

6.  Enterococcus faecalis enhances cell proliferation through hydrogen peroxide-mediated epidermal growth factor receptor activation.

Authors:  Kanitsak Boonanantanasarn; Ann Lindley Gill; YoonSing Yap; Vijayvel Jayaprakash; Maureen A Sullivan; Steven R Gill
Journal:  Infect Immun       Date:  2012-07-30       Impact factor: 3.441

7.  A specific A/T polymorphism in Western tyrosine phosphorylation B-motifs regulates Helicobacter pylori CagA epithelial cell interactions.

Authors:  Xue-Song Zhang; Nicole Tegtmeyer; Leah Traube; Shawn Jindal; Guillermo Perez-Perez; Heinrich Sticht; Steffen Backert; Martin J Blaser
Journal:  PLoS Pathog       Date:  2015-02-03       Impact factor: 6.823

8.  Increased ERK signalling promotes inflammatory signalling in primary airway epithelial cells expressing Z α1-antitrypsin.

Authors:  Emily F A van 't Wout; Jennifer A Dickens; Annemarie van Schadewijk; Imran Haq; Hang Fai Kwok; Adriana Ordóñez; Gillian Murphy; Jan Stolk; David A Lomas; Pieter S Hiemstra; Stefan J Marciniak
Journal:  Hum Mol Genet       Date:  2013-10-04       Impact factor: 6.150

9.  Toll-like receptors expression in follicular cells of patients with poor ovarian response.

Authors:  Seyed Abdolvahab Taghavi; Mahnaz Ashrafi; Mehdi Mehdizadeh; Leili Karimian; Mohammad Taghi Joghataie; Reza Aflatoonian
Journal:  Int J Fertil Steril       Date:  2014-07-08

10.  Chronic macrophage migration inhibitory factor exposure induces mesenchymal epithelial transition and promotes gastric and colon cancers.

Authors:  Katherine T Morris; Robert A Nofchissey; Irina V Pinchuk; Ellen J Beswick
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.